Carlisle Companies Incorporated (CSL)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 1,772,700 1,732,500 1,753,800 775,100 684,500 736,100 725,200 832,100 924,000 877,900 765,300 563,100 421,700 374,200 334,400 310,500 320,100 342,100 377,700 455,200
Total stockholders’ equity US$ in thousands 2,463,300 2,762,900 3,004,300 2,859,300 2,829,000 2,923,800 3,032,000 3,058,300 3,024,400 3,041,700 2,875,100 2,678,600 2,629,500 2,544,800 2,417,900 2,411,800 2,537,700 2,475,300 2,516,200 2,518,500
ROE 71.96% 62.71% 58.38% 27.11% 24.20% 25.18% 23.92% 27.21% 30.55% 28.86% 26.62% 21.02% 16.04% 14.70% 13.83% 12.87% 12.61% 13.82% 15.01% 18.07%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $1,772,700K ÷ $2,463,300K
= 71.96%

Carlisle Companies Incorporated's return on equity (ROE) has shown fluctuations over the past few years. The ROE declined from 18.07% in March 2020 to a low of 12.61% in December 2020, indicating a decrease in profitability relative to shareholders' equity. However, there was a gradual improvement in ROE from March 2021 to June 2022, with a peak of 30.55% in December 2022, reflecting enhanced profitability efficiency.

Subsequently, the ROE experienced a slight decline in the first quarter of 2023 but rebounded to 58.38% in June 2024, demonstrating a significant surge in profitability compared to the equity base. The ROE continued its upward trajectory, reaching 71.96% by the end of December 2024, indicating a strong performance in generating returns for shareholders.

Overall, Carlisle Companies Incorporated exhibited varying levels of ROE, with fluctuations reflecting changes in the company's profitability and efficiency in utilizing shareholders' equity to generate earnings. The recent trend of increasing ROE highlights the company's improved financial performance and potential for enhanced shareholder value.


Peer comparison

Dec 31, 2024

Company name
Symbol
ROE
Carlisle Companies Incorporated
CSL
71.96%
West Pharmaceutical Services Inc
WST
18.37%